Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Kanno

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|January 21, 2023
The uPA/uPAR System Orchestrates the Inflammatory Response, Vascular Homeostasis, and Immune System in Fibrosis ProgressionYosuke Kanno
Current Issues in Molecular Biology|October 28, 2025
Pathogenic and Regulatory Roles of Fibrinolytic Factors in Autoimmune DiseasesYosuke Kanno
Cells|March 27, 2024
The Roles of Fibrinolytic Factors in Bone Destruction Caused by InflammationYosuke Kanno
International Journal of Molecular Sciences|February 3, 2019
The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic SclerosisYosuke Kanno
Current Pharmaceutical Design|March 7, 2006
The possibility of novel antiplatelet peptides: the physiological effects of low molecular weight HSPs on plateletsYosuke Kanno, Hiroyuki Matsuno
Life (Basel, Switzerland)|March 25, 2022
α2-Antiplasmin as a Potential Therapeutic Target for Systemic SclerosisYosuke Kanno, En Shu
Chemical Communications (Cambridge, England)|July 16, 2008
Facile unidirectional alignment of mesochannels in a mesoporous silica film on a freshly cleaved mica surfaceTakashi Suzuki, Yosuke Kanno, Yuji Morioka, et al.
Immunity, Inflammation and Disease|April 3, 2020
α2AP is associated with the development of lupus nephritis through the regulation of plasmin inhibition and inflammatory responsesYosuke Kanno, Mei Miyashita, Mariko Seishima, et al.
Molecular Medicine Reports|September 18, 2020
Decrease in matrix metalloproteinase‑3 activity in systemic sclerosis fibroblasts causes α2‑antiplasmin and extracellular matrix deposition, and contributes to fibrosis developmentHirofumi Niwa, Yosuke Kanno, En Shu, et al.
The Journal of Investigative Dermatology|January 9, 2016
The Antifibrotic Effect of α2AP Neutralization in Systemic Sclerosis Dermal Fibroblasts and Mouse Models of Systemic SclerosisYosuke Kanno, En Shu, Hiroyuki Kanoh, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|January 21, 2023
The uPA/uPAR System Orchestrates the Inflammatory Response, Vascular Homeostasis, and Immune System in Fibrosis ProgressionYosuke Kanno
Current Issues in Molecular Biology|October 28, 2025
Pathogenic and Regulatory Roles of Fibrinolytic Factors in Autoimmune DiseasesYosuke Kanno
Cells|March 27, 2024
The Roles of Fibrinolytic Factors in Bone Destruction Caused by InflammationYosuke Kanno
International Journal of Molecular Sciences|February 3, 2019
The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic SclerosisYosuke Kanno
Current Pharmaceutical Design|March 7, 2006
The possibility of novel antiplatelet peptides: the physiological effects of low molecular weight HSPs on plateletsYosuke Kanno, Hiroyuki Matsuno
Life (Basel, Switzerland)|March 25, 2022
α2-Antiplasmin as a Potential Therapeutic Target for Systemic SclerosisYosuke Kanno, En Shu
Chemical Communications (Cambridge, England)|July 16, 2008
Facile unidirectional alignment of mesochannels in a mesoporous silica film on a freshly cleaved mica surfaceTakashi Suzuki, Yosuke Kanno, Yuji Morioka, et al.
Immunity, Inflammation and Disease|April 3, 2020
α2AP is associated with the development of lupus nephritis through the regulation of plasmin inhibition and inflammatory responsesYosuke Kanno, Mei Miyashita, Mariko Seishima, et al.
Molecular Medicine Reports|September 18, 2020
Decrease in matrix metalloproteinase‑3 activity in systemic sclerosis fibroblasts causes α2‑antiplasmin and extracellular matrix deposition, and contributes to fibrosis developmentHirofumi Niwa, Yosuke Kanno, En Shu, et al.
The Journal of Investigative Dermatology|January 9, 2016
The Antifibrotic Effect of α2AP Neutralization in Systemic Sclerosis Dermal Fibroblasts and Mouse Models of Systemic SclerosisYosuke Kanno, En Shu, Hiroyuki Kanoh, et al.
Pageof 5